Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesPercutaneous treatment of lymphatic malformations
Otolaryngology Head and Neck Surgery, 08/06/09
vertigo WE et al. – Percutaneous sclerotherapy provides effective treatment for macrocystic and microcystic LM as primary treatment or for recurrence after surgical resection.
Related Articles
Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09
Relevance Score: 71%
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09
Relevance Score: 71%
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09
Relevance Score: 69%
Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09
Relevance Score: 69%
Progesterone receptors identified in vascular malformations of the head and neck
Otolaryngology Head and Neck Surgery, 10/09/09
Relevance Score: 69%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Secondary surgery in paediatric facial paralysis reanimation
Journal of Plastic, Reconstructive & Aesthetic Surgery, 12/18/09
Can occlusal devices prolong the effect of botulinum toxin type A in the contouring of the lower face
European Journal of Plastic Surgery, 12/17/09
Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma
Journal of Gastroenterology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor